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Background: Loss of cortical volume in frontotemporal regions has been reported in patients with schizophrenia and their relatives.
Cortical area and thickness are determined by different genetic processes, and measuring these parameters separately may clarify
disturbances in corticogenesis relevant to schizophrenia. Our study also explored clinical and cognitive correlates of these parameters.
Methods: Thirty-sevenpatientswithﬁrst-episodepsychosis(34schizophrenia,3schizoaffectivedisorder)and38healthycontrolsubjects
matched for age and sex took part in the study. Imaging was performed on an magnetic resonance imaging 1.5-T scanner. Area and
thickness of the frontotemporal cortex were measured using a surface-based morphometry method (Freesurfer). All subjects underwent
neuropsychologic testing that included measures of premorbid and current IQ, working and verbal memory, and executive function.
Results: Reductionsincorticalarea,moremarkedinthetemporalcortex,werepresentinpatients.Overallfrontotemporalcorticalthickness
did not differ between groups, although regional thinning of the right superior temporal region was observed in patients. There was a
signiﬁcantassociationofbothpremorbidIQandIQatdiseaseonsetwitharea,butnotthickness,ofthefrontotemporalcortex,andworking
memoryspanwasassociatedwithareaofthefrontalcortex.Theseassociationsremainedsigniﬁcantwhenonlypatientswithschizophrenia
were considered.
Conclusions: Ourresultssuggestanearlydisruptionofcorticogenesisinschizophrenia,althoughtheeffectofsubsequentenvironmental
factors cannot be excluded. In addition, cortical abnormalities are subject to regional variations and differ from those present in neurode-
generative diseases.
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episodepsychosis,frontotemporalcortex,magneticresonanceim-
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C
ortical volume is genetically determined with heritability
(1) decreasing over time as environmental factors become
relevant (2). The cortex is shaped in utero by the strength
of interregional connectivity, and cortical changes are to be
expected in schizophrenia, a disease with abnormal brain con-
nectivity (3,4).
Meta-analyses of voxel-based morphometry studies identified
gray matter loss in corticosubcortical networks involving fronto-
temporal and limbic cortex, thalamus, and striatum in chronic
schizophrenia (5–7), and less extensive changes have also been
reported in those with first-episode (8), schizotypal disorder, and
high-risk individuals (9–12). Subtle cortical abnormalities, with-
out volume loss, have been described using magnetization
transfer imaging in first-episode psychosis (13,14).
Surface-based morphometry (SBM) methods allow the inde-
pendent measurement of cortical area and thickness—indexes
that share a high heritability but are determined by different
genetic mechanisms (15). Freesurfer (16), an SBM method with
realistic cortical reconstruction that allows for manual correction
of topological errors (17), uses a segmentation procedure based
on the identification of gray–white matter and gray matter–pial
boundaries, as well as a surface-based registration that aligns
cortical folding patterns. Freesurfer has an accuracy of .2 mm (18)
compared with postmortem measures of cortical thickness and
has been validated using different scanners and magnetic reso-
nance imaging (MRI) protocols (16).
Studies using SBM have mainly measured regional or whole
cortical thickness. Frontotemporal gyral and sulcal thinning has
been reported in children and adolescents (19,20) and in young
adults with first-episode schizophrenia by some (21,22) but not
others (23). Cortical thinning, particularly prefrontal, followed a
developmental trajectory different from that of control subjects
(24,25). In chronic patients, thinning of the entorhinal (26) and
frontotemporal cortex with relative sparing of somatosensory
(27) and parietal cortex (28) has also been reported and changes
in cortical thickness in the cingulate and temporal regions may
represent the unexpressed genetic liability in relatives of schizo-
phrenia patients (29).
Cortical area has been less frequently measured with contra-
dictory results. Thus, although reduced area in paralimbic ventral
frontal cortex in drug-naive patients (30) and in posterior cingu-
late in those with chronic schizophrenia and their relatives has
been described (31), other studies (32) have reported area
increases in the anterior cingulate. Early reports of decreased
insular area in first-episode patients (30) have not been repli-
cated (33). A study of patients with adolescent-onset schizophre-
nia (34) identified widespread, regionally variable cortical pa-
thology in prefrontal and superior temporal gyrus, with variable
reductions in area and/or thickness. Similar changes have been
reported in unaffected relatives (35), and severity of positive symp-
toms has been associated with decrease entorhinal area (26).
We report here an exploratory study in patients with first-
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measured using SBM in frontal and temporal cortex, regions
known to be implicated in schizophrenia. We aimed to clarify the
pattern of cortical abnormalities, whether changes in area and
cortical thickness occurred independently, and their possible
associations with clinical and cognitive measures.
Methods and Materials
Subjects
Patients were part of a cohort recruited for the West London
Longitudinal First-Episode Psychosis Study (36), aged between
16 and 49 years at recruitment, who had been receiving antipsy-
chotic medication for less than 12 weeks. Diagnosis was ascer-
tained using the diagnostic module of the Diagnostic Interview
for Psychosis (DIP-DM) (37), which includes items from the
Operational Criteria Checklist for Psychosis (38) and the World
Health Organization Schedules for Clinical Assessment in Neu-
ropsychiatry (39). Two nurses trained by an experienced psychi-
atrist (T.R.E.B.) conducted the interviews.
Forty-one patients who had MRI and neuropsychologic as-
sessments participated. Four were excluded because of poor-
quality MRI data. Thirty-seven patients (25 males) were included;
34 had a final diagnosis of schizophrenia and 3 had schizoaffec-
tive disorder (1 bipolar, 2 depressed subtypes). Mean age was
26.8 years (SD  8.8; range, 16–49). The study was naturalistic
with no restrictions on prescribed medication; all patients were
prescribed antipsychotics (36 second-generation, 1 first-genera-
tion), and 8 were also prescribed antidepressants. At the time of
scanning, the median duration of treatment was 102 days (range,
0384), and 17 patients had received treatment for more than 12
weeks. Thirty-eight healthy subjects (22 males) who had neuro-
psychologic assessment and MRI served as control subjects. Their
mean age was 25.0 years (SD  5.4; range, 16–37). Exclusion
criterion for all subjects, was the presence of a medical or
neurological illness, including head injury leading to uncon-
sciousness. Controls with psychiatric illness in themselves or
their first-degree relatives were excluded.
Clinical Ratings
Mental state was assessed with the Scales for the Assessment
of Positive and Negative Symptoms (SAPS and SANS) (40,41).
Interrater agreement (linearly weighted kappa) was assessed
using a standard set of videotaped interviews. Using global
subscale items, linearly weighted kappas of .76 for SAPS and .74
for SANS were achieved (42). Scores for the three symptom-
derived syndromes (negative, positive, and disorganization)
were calculated (43). Affective symptoms were measured with
the Young Mania Scale (44) and Hamilton Rating Scale for
Depression (45). Age of onset and duration of untreated psycho-
sis (DUP) were established using the Symptom Onset in Schizo-
phrenia Inventory (46). Alcohol and drug use were assessed
using the DIP (37), and criteria for abuse and dependence using
the Alcohol and Drug Use Scales (47). None of the subjects
fulfilled these criteria. Handedness was assessed using the Annett
Scale (48).
Ethical permission was obtained from the local ethics com-
mittees. Participants gave written informed consent according to
the Declaration of Helsinki and received an honorarium.
Neuropsychological Assessment
Premorbid IQ was estimated using the Revised National Adult
Reading Test (49), validated in schizophrenia (50,51). Current IQ
was measured using a short form of the Wechsler Adult Intelli-
gence Scale—III (52) validated for schizophrenia (53), compris-
ing the Information, Arithmetic, Block Design, and Digit Symbol
subtests. Measures of executive function were derived from the
Cambridge Neuropsychological Test Automated Battery (54): 1)
Working memory span, from the Spatial Span Task, measures the
ability to remember the order of sequences of colored squares
presented in increasing numbers. The span was measured as the
highest number recalled correctly. 2) Working memory manip-
ulation, from the Spatial Working Memory Task, a self-ordered
search task measures the ability to remember the location of
previously found “tokens” while searching for new ones. An
error occurs when a participant returns to the location where a
token has already been found. Total errors were used as an index
of working memory manipulation. 3) Planning, from the Stock-
ings of Cambridge task (55), measures the ability to move
colored “balls” in an arrangement displayed on the screen to
match a goal arrangement. The number of problems solved in
the minimum number of moves possible was the score.
Verbal memory was assessed with the Rey Auditory Verbal
Learning Test (56). The participant is asked to recall nouns from
a list of 15 immediately after each of five trials. The number of
words recalled over the five trials was the final score.
MRI Data Acquisition
The MRIs were performed on a GE Signa 1.5-Tesla scanner
(General Electric, Milwaukee, Wisconsin), using a standard
quadrature head coil. T1-weighted volumetric images were
obtained using an inversion recovery spoiled gradient-recalled
echo sequence with an isotropic voxel size of 1.2  1.2  1.2
mm
3. One hundred twenty-four axial contiguous slices were
acquired. Other parameters were echo time (5.4 msec), repetition
time (15 msec), inversion time (450 msec), field of view  31  16
cm
2, acquisition matrix 256  128, number of averages  1,
excitation flip angle  15°, and receiver bandwidth  15.63 kHz.
Image Processing
A rater (L.G.G.), blind to participant status, used Freesurfer
4.0.1 (http://surfer.nmr.mgh.harvard.edu) to generate maps of
surface area and cortical thickness in standard Montreal Neuro-
logical Institute (MNI) space (57,58). After skull stripping and
white matter segmentation, the cortical surface of each hemi-
sphere was inflated to an average spherical surface to locate the
pial surface and the gray–white matter boundary (57). The
distance between the two at each vertex (i.e., surface point)
across the cortex is considered a measure of cortical thickness.
Cortical maps are smoothed with a 10-mm full-width at half-
maximum Gaussian kernel and aligned to a common surface
template using a high-resolution surface-based averaging tech-
nique, and 32 cortical parcellations are automatically generyated
(59). The only manual step was the correction of topological
errors when the above steps had been completed. Total brain
volume was estimated using Freesurfer (60).
Analysis of Cortical Parameters
Two comparisons were made between patients and controls:
1) whole-brain cortical thickness using the “vertex-by-vertex”
analysis; and 2) cortical thickness, surface area, and volume in
frontal and temporal regions.
From the Desikan template (59), six frontal and six temporal
parcellations in each hemisphere were selected. Superior frontal,
pars opercularis, caudal middle frontal, rostral middle frontal,
caudal anterior cingulate, and rostral anterior cingulate were
selected in the frontal lobe; in the temporal lobe, the superior,
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transverse temporal parcellations were selected (Figure 1). Av-
erage thickness, total surface area, and volume of the cortex for
the frontal and temporal regions covered by these parcellations
were calculated for each hemisphere and compared between the
two groups.
Statistical Analysis
Demographic and Cognitive Variables. Age, sex, total brain
volume, and handedness were compared between groups using
t and chi-square tests. Linear regression models adjusted by age
and sex were used to compare cognitive scores.
Imaging Variables. Age and sex were used as covariates in
all models.
For the comparison of whole brain cortical thickness, the
vertex-by-vertex analysis was used, and means of cortical thick-
ness were compared between groups using a two-tailed t test;
cortical thickness was modeled as a function of group controlling
for age and sex. Corrections for multiple comparisons were made
using a false discovery rate (FDR), setting the level of significance
at .05 (61).
Linear mixed models were used for the following compari-
sons of frontal and temporal cortical parameters between the
groups: 1) differences due to diagnostic group, region, and side,
with two-way interactions (diagnosis by region, diagnosis by
side, and region by side); 2) differences due to sex; age; duration
of treatment; DUP; and positive, negative, and disorganization
syndrome scores with two-way interactions by region and side;
and 3) associations between cognitive scores and cortical param-
eters with two- and three-way interactions. Region was entered
as a within-subject effect and diagnosis, cognitive scores, sex,
and age as between-subject effects. Three separate models were
created for thickness, surface area, and cortical volume that
allowed the inclusion of multiple measurements for each subject
and the handling of missing data, thereby increasing statistical
power (62). As in previous studies (27,34,63), we did not control
for brain volume, a schizophrenia-related variable, because this
would have obscured possible group differences.
We repeated the same model with two-way interaction (di-
agnosis by region) to identify cortical differences in each of the
six frontal or temporal parcellations. When significant interac-
tions were present, the linear mixed model was repeated with
the corresponding indicators and interaction terms for the re-
gional parcellations.
For these exploratory analyses significance was reported at
the 5% level with no formal adjustment made for multiple
comparisons, because this may be inappropriate (64,65) when
no single null hypothesis covers the multiple tests. To highlight
the strongest associations, we also report the linear regression
results using FDR setting the level of significance at .05.
Results
Age, total brain volume, and sex did not differ between
groups. Fewer patients (2 of 37) than control subjects (7 of 38)
were left-handed, although this difference was not statistically
significant. All cognitive scores were significantly worse in
patients (at trend level for premorbid IQ; Table 1). Duration of
treatment and DUP, positive, negative, and disorganization
scores are shown on Table 1.
Group Differences in Cortical Parameters
Analyses were performed with and without three patients
with schizoaffective disorder. Results remained unchanged when
the latter were excluded and findings for the whole group are
reported (Table 2).
Whole-brain cortical thickness (vertex by vertex) did not
differ between groups.
Cortical parameters in frontal and temporal regions: 1) Corti-
cal thickness did not vary by diagnosis or sex. Age was more
closely associated with thinning in the frontal than in the
temporal cortex (regional mean difference in thinning per year 
.0085 mm/year; 95% confidence interval [CI] .0113 to .0057;
p  .001], with thinning of .0073 mm/year (95% CI .0109 to
.0038; p  .001) in the frontal region. 2) Cortical area was not
related to age or side in frontal or temporal regions but was larger
in male subjects irrespective of diagnosis (regional mean differ-
ence between males and females  416.13 mm
2; 95% CI 153.16
to 679.09); p  .002) and more so for the frontal (sex mean
difference  2679.29 mm
2; 95% CI 1995.44 to 3363.13; p  .001)
than the temporal regions (sex mean difference  2263.16 mm
2;
95% CI 1579.32 to 2947.01; p  .001). In patients, temporal
cortical area was smaller than in controls (regional means
difference in patients  724.12 mm
2; 95% CI –1369.56 to
–78.69; p  .028), explained by the smaller area in the superior
(95% CI –326.42 to –67.32; p  .003), middle (95% CI 291.31 to
32.21; p  .014) and inferior (95% CI 271.43 to 12.33; p 
.032) temporal parcellations. FDR-corrected analysis showed a
reduction in right superior temporal area in patients (mean
difference between patients and control subjects  206.74
mm
2; 95% CI 354.87 to 58.62); p  .028). In a post hoc
multiple linear regressions of cortical thickness in these three
parcellations, adjusted for age and sex, thickness was only
reduced in the right superior temporal parcellation (mean differ-
ence between patients and control subjects  .0751 mm; 95%
CI .1363 to .0139; p  .017). There were no significant
Figure1.Lateralandmidsagittalviewsofthefrontalandtemporalparcellations:1,superiorfrontal;2,rostralmiddlefrontal;3,caudalmiddlefrontal;4,pars
opercularis; 5, rostral anterior cingulate; 6, caudal anterior cingulate; 7, superior temporal; 8, middle temporal; 9, inferior temporal; 10, transverse temporal;
11, temporal pole; 12, fusiform.
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cortical volume was smaller in patients (regional mean difference
in patients  2183.94 mm
3; 95% CI 4104.17 to 263.70; p 
.026), explained by reductions in the volume of the superior
(95% CI 1052.96 to 216.31; p  .003), middle (95% CI
936.38 to 99.73; p  .015), inferior temporal (95% CI 938.57
to 101.92; p  .015), and fusiform (95% CI 939.37 to 102.72;
p  .015) parcellations. Left frontal cortical volume was larger
than right (mean difference between sides  740.47 mm
3; 95% CI
42.03 to 1438.91; p  .038). There were no group differences in
the temporal cortical volume (mean difference between sides 
218.41 mm
3; 95% CI 916.85 to 480.03; p  .540). 4) Cortical
parameters were not associated with duration of treatment or
DUP or syndrome scores. In a post hoc analysis of parcellations
with reduced cortical area, using linear regressions adjusted for
DUP, age, and sex, a trend level association with treatment
duration (area increase of 1.46 mm
2/day of untreated psychosis;
95% CI .04 to 2.97; p  .056) was present for the superior
temporal parcellation.
Cortical Parameters and Cognition
Whole group and the schizophrenia-only subgroup results are
given for working memory because minor differences occurred
when schizoaffective disorder patients were excluded.
Premorbid IQ. In patients there was a significant association
between cortical area and premorbid IQ for frontal and temporal
regions (mean difference of regional area increase per IQ point
 6.04 mm
2; 95% CI 8.35 to 20.43; p  .411). Higher premorbid
IQ was associated with larger frontal cortical area (increase of
46.01 mm
2 per premorbid IQ point; 95% CI 11.13 to 80.88; p 
.010) accounted for by superior frontal parcellation (95% CI 2.91
to 23.05; p  .012). Higher premorbid IQ was associated with
larger temporal cortical area (increase of 39.97 mm
2; 95% CI 5.09
to 74.84; per IQ point; p  .025). The middle (95% CI 3.28 to
17.48; p  .004), inferior temporal (95% CI .41 to 14.61; p  .038),
and fusiform (95% CI 4.19 to 18.39; p  .002) parcellations
accounted for this association. No such associations were present
in control subjects (Figures 2–6). No significant associations
survived FDR correction.
In patients, there was a significant association between corti-
cal volume and premorbid IQ for both frontal and temporal
regions (mean difference of regional volume increase per IQ
point  26.80 mm
3; 95% CI 27.26 to 80.87; p  .311). Higher
premorbid IQ was associated with larger frontal cortical volume
(increase of 151.87 mm
3 per IQ point; 95% CI 48.91 to 254.84; p
 .004) accounted for by the volumes of the superior (95% CI
23.40 to 81.83; p  .001) and rostral middle (95% CI 2.85 to 61.28;
p  .031) parcellations. Higher premorbid IQ was also associated
with temporal cortical volume (increase of 125.07 mm
3 per IQ
point; 95% CI 22.11 to 228.03; p  .017). The volumes in superior
(95% CI 5.69 to 51.32; p  .014), middle (95% CI 12.61 to 58.25;
p  .002), inferior (95% CI .36 to 45.99; p  .047), and fusiform
(95% CI 13.94 to 59.58; p  .002) parcellations accounted for the
association. These associations were not present in controls.
Current IQ. In patients, current IQ had a stronger association
with frontal than temporal cortical area (mean difference of
regional area increase per IQ point  14.56 mm
2; 95% CI 4.13 to
Table 1. Demographic and Cognitive Measures in Patients and Controls
Variable Measured Patients (n  37) Control Subjects (n  38) Comparison
Age (years) 26.8 (8.8) [16–49] 25.0 (5.4) [16–37] t(73)  1.06, p  .291
Male Sex, n (%) 25 (67.6) 22 (57.9) 
2(1)  .75, p  .387
Left-Handed, n (%) 2 (5.4) 7 (18.4) 
2(1)  3.01, p  .083
Total Brain Volume (mm
3) 1543685 (198405.4) 1571956 (188197.2) t(73)  .63, p  .529
Premorbid IQ 99.8 (12.9) [73–120] 105.3 (11.2) [74–120] t(74)  1.99, p  .051
Current IQ 89.6 (17.6) [61–135] 110.6 (15.0) [81–140] t(74)  5.63, p  .001
Working Memory Span 5.5 (1.6) [2–9] 6.5 (1.2) [4–9] t(74)  3.24, p  .002
Planning 7.2 (2.7) (012) 8.8 (1.6) [6–12] t(74)  3.12, p  .003
Working Memory Manipulation 33.9 (16.7) (058) 15.4 (14.3) (060) t(74)  5.26, p  .001
Rey Auditory Verbal Learning Test 38 (8.4) [14–52] 49.4 (10.4) [18–64] t(74)  5.03, p  .001
Duration of Treatment (days) 80 (56) [9–186] NA NA
Duration of Untreated Psychosis (months) 10.4 (22.8) (0126) NA NA
Factor 1, Negative Syndrome .29 (.25) (0.8) NA NA
Factor 2, Positive Syndrome .75 (.20) (01) NA NA
Factor 3, Disorganization Syndrome .27 (.25) (0.8) NA NA
Values are means (SD) [range].
NA, not applicable.
Table 2. Cortical Parameters in Frontal and Temporal Regions in Patients and Controls Unadjusted by Age or Gender
Region of
Cortex
Thickness (mm)
a Surface Area (mm
2)
b Volume (mm
3)
b
Patients Controls Patients Controls Patients Controls
Frontal
Left 2.71 (.15) 2.70 (.13) 15680.59 (2086.42) 16048.87 (1989.18) 47014.73 (6395.26) 47862.50 (4818.93)
Right 2.73 (.15) 2.69 (.13) 15567.30 (2252.66) 15773.68 (1960.96) 46597.27 (6766.11) 46807.53 (4788.16)
Temporal
Left 2.72 (.13) 2.71 (.11) 13782.35 (1557.68) 14275.03 (1803.94) 43358.57 (5253.97) 44940.76 (4817.45)
Right 2.73 (.15) 2.75 (.12) 13795.49 (1652.54) 14183.13 (1731.98) 43539.14 (5047.07) 45196.03 (4879.04)
aValues are means (SD).
bValues are means (SD) of the sums of six parcellations each.
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2 per IQ point
(95% CI 19.89 to 69.97; p  .001). The superior (95% CI 10.35 to
24.85; p  .001), rostral middle (95% CI 6.38 to 20.87; p  .001),
and caudal middle (95% CI .04 to 14.54; p  .049) parcellations
accounted for the association. There was an increase of 30.37
mm
2 per IQ point (95% CI 5.33 to 55.41; p  .017) in the temporal
cortical area. The middle (95% CI 3.87 to 14.17; p  .001), inferior
(95% CI 1.43 to 11.73; p  .012) and fusiform (95% CI 7.17 to
17.48; p  .001) parcellations accounted for this association.
Associations remained significant after FDR correction for the
right fusiform (95% CI 6.23 to 21.89; p  .012) and rostral middle
frontal (95% CI 5.27 to 23.86; p  .016) parcellations. No
significant associations were found in controls (Figures 2–6).
In patients there was a significant association between cortical
volume and current IQ for frontal and temporal regions (mean
difference of regional volume increase per IQ point  33.72
mm
3; 95% CI 5.84 to 73.28; p  .095), with an increase of
131.99 mm
3 of frontal cortical area per IQ point (95% CI 57.62 to
206.35; p  .001). The superior (95% CI 38.65 to 80.88; p  .001),
rostral middle (95% CI 10.51 to 52.75; p  .003), and caudal
middle (95% CI .60 to 42.84; p  .044) parcellations accounted
for this association. Temporal cortical volume increased by 98.27
mm
3 per IQ point (95% CI 23.90 to 172.63; p  .010) and the
superior (95% CI 2.87 to 36.04; p  .022), middle (95% CI 13.41
to 46.59; p  .001, inferior (95% CI 3.98 to 37.15; p  .015), and
fusiform (95% CI 22.49 to 55.66; p  .001) parcellations ac-
counted for this association. No significant associations were
present for controls.
Figure3.ScatterplotoftheassociationsbetweenpremorbidIQandcurrent
IQ with the average cortical area for the right and left hemispheres in
patients and controls: rostral middle frontal.
Figure2.ScatterplotoftheassociationsbetweenpremorbidIQandcurrent
IQ with the average cortical area for the right and left hemispheres in
patients and controls: superior frontal.
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association with larger frontal cortical area (281.43 mm
2 increase
in area per score point; 95% CI 13.83 to 576.68; p  .062) that
reached significance when schizoaffective disorder patients were
excluded (95% CI 8.99 to 696.42; p  .044).
In patients, there was a stronger association with frontal than
temporal cortical volume (mean difference of regional volume
increase per score point  569.12 mm
3; 95% CI 123.13 to
1015.11; p  .012), with an increase of 962.94 mm
3 per score
point (95% CI 86.24 to 1839.64; p  .031); the superior frontal
parcellation accounted for this association (95% CI 260.72 to
744.35; p  .001). No significant associations were present for
control subjects.
Cortical thickness was not associated with IQ or working
memory span. Scores of planning, working memory manipula-
tion, and Rey Auditory Verbal Learning Test were not signifi-
cantly associated with cortical parameters. There were no signif-
icant associations by side for any cognitive variable.
Discussion
Reduction in cortical volume, predominantly in temporal
regions, due to smaller cortical area in patients with first-episode
psychosis was our main finding, and area reductions were
closely related to cognitive performance. Cortical thinning was
only present in the right superior temporal region.
Our findings contrast with those of others reporting cortical
thinning in patients with childhood (66,67), early-adulthood, or
Figure5.ScatterplotoftheassociationsbetweenpremorbidIQandcurrent
IQ with the average cortical area for the right and left hemispheres in
patients and controls: inferior temporal.
Figure4.ScatterplotoftheassociationsbetweenpremorbidIQandcurrent
IQ with the average cortical area for the right and left hemispheres in
patients and controls: middle temporal.
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Voets et al. (34), who reported reduced area and thickness in
overlapping cortical regions, are closer to our own. These
differences may be partly explained by the more severely
compromised brain maturation trajectory in early onset schizo-
phrenia (68,69). Methodologic variations may also be relevant.
Thus, surface measurements in native space from the Desikan
parcellations, used by Voets and colleagues (34) and ourselves,
may be more sensitive than metric distortion used by others to
estimate changes in cortical area.
The human brain is characterized by an expansion in the size
and complexity of association areas in the neocortex (70),
particularly prefrontal cortex (71), largely because of increased
cortical area with little change in cortical thickness (72). In early
fetal development, cortical area is determined by the migration of
radial columns from the ventricular zone to the cortical plate
(73,74), followed by the asymmetrical division of precursor cells
in the ventricular zone and subsequent migration to the cortical
plate increasing its thickness but not its area. Although neuronal
migration is complete by the 25th week of gestation, glial
migration and growth of cortical connections continue for longer
with further increases in cortical surface, which is also influenced
by differential expansion of cortical layers (75). Our finding of
reduced area, without change in cortical thickness suggests a
disruption of corticogenesis at a time of rapid cortical expansion,
that is, late pregnancy and the perinatal period. Contemporary
white matter abnormalities may have further reduced cortical
area, as is thought to be the case in very low-birth-weight
adolescents in whom area reduction is greater than cortical
thinning (76,77). The reduction of brain volume over the first 2
decades of illness (78–80) suggests that mechanisms operating
around disease onset may also be relevant. Regional gray matter
changes may also be induced by atypical and typical antipsy-
chotics (81), although we failed to find an association with
treatment duration.
The pattern of cortical abnormalities reported here differs
from that in degenerative conditions. Cortical thinning without
area changes has been reported in early Huntington disease (18)
and in Alzheimer’s disease (85,86), validated at postmortem in
the latter using stereologic methods (87).
We did not find significant correlations between cortical
abnormalities and symptom severity, in keeping with other
(82,83), but not all (84), SBM studies, but we found a strong
association between IQ and frontotemporal cortical area. Gen-
eral intelligence depends on neural networks critically involving
frontal and parietal cortex (88,89). It has high heritability and
correlates strongly with gray matter volume (90,91) in normal
twins (92) and singletons (93). These studies have mainly
measured cortical thickness (94–96), which is modified by
experience-dependent plasticity (97). Cognitive impairment, in-
tegral to schizophrenia (98), is best characterized by a general-
ized deficit (99,100). Those with schizophrenia have lower IQs
than their childhood peers (101), and 40%–45% may decline
further by illness onset (102–107). This is supported by the closer
correlation between cortical area and current rather than premor-
bid IQ in our patients. We have previously reported that premor-
bid IQ and IQ at illness onset are prognostic indicators of clinical
outcome 3 to 4 years later (106,108). The association between
cortical area and IQ reported here suggests that cortical area
changes may have prognostic relevance.
There are limitations to our study. Abnormalities in other than
frontotemporal cortical areas cannot be excluded. It remains
possible, although unlikely, that changes in cortical thickness
could have been detected in a larger sample. However, Free-
surfer reliability studies (109) suggest that differences in cortical
thickness of less than .1 mm could have been detected with our
sample size. Moreover, in a more detailed, regional analysis,
cortical thinning was only present in one (the right superior
temporal) of several temporal parcellations with reduced area
suggesting that cortical abnormalities vary in different regions.
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